产品
编 号：F049767
分子式：C28H42Cl4N4O2
分子量：608.47
分子式：C28H42Cl4N4O2
分子量：608.47
产品类型
规格
价格
是否有货
结构图
CAS No: 115-79-7
产品详情
生物活性：
Ambenonium (WIN 8077) chloride is an orally active and reversible inhibitor of Acetyicholinesterase (AChE) with high affinity. Ambenonium chloride inhibits human AChE with an IC50 value of 0.7 nM (hAChE).
体内研究：
Ambenonium chloride (6 mg/kg; p.o.; daily; 30-60 d) results an adverse effect on neuromuscular transmission in long-term administration, and induces hypersensitivity to stimulation in myasthenia gravis mice modle.Ambenonium chloride (6 mg/kg; p.o.; daily; 14 d) decreases the number of AChR in motorend-plates.Animal Model:Female Sprague Dawley rats (weight 250 g) with myasthenia gravis
Dosage:6 mg/kg
Administration:Oral gavage; daily; 14, 30, 60, 90, 360 days (Stop administration 24 h in advance)
Result:Resulted general activity decreasing and hypersensity to stimulation in rats during day 30-60, but these behaviors disappeared on day 90.Induced degeneration and simplification of the postsynaptic folds, widening of the synaptic clefts, increased number of the postsynaptic vesicles, and reduction in the number of the AChR in the postsynaptic membrane on days 360.
体外研究：
Ambenonium chloride inhibits Acetyicholinesterase (AChE) in a rapidly reversible method, and shows strong inhibition with inhibition constant Ki of 0.12 nM against hAChE.Ambenonium chloride shows inhibitory effect towards BChE with an IC50 value of 7 μM (hBChE).
Ambenonium (WIN 8077) chloride is an orally active and reversible inhibitor of Acetyicholinesterase (AChE) with high affinity. Ambenonium chloride inhibits human AChE with an IC50 value of 0.7 nM (hAChE).
体内研究：
Ambenonium chloride (6 mg/kg; p.o.; daily; 30-60 d) results an adverse effect on neuromuscular transmission in long-term administration, and induces hypersensitivity to stimulation in myasthenia gravis mice modle.Ambenonium chloride (6 mg/kg; p.o.; daily; 14 d) decreases the number of AChR in motorend-plates.Animal Model:Female Sprague Dawley rats (weight 250 g) with myasthenia gravis
Dosage:6 mg/kg
Administration:Oral gavage; daily; 14, 30, 60, 90, 360 days (Stop administration 24 h in advance)
Result:Resulted general activity decreasing and hypersensity to stimulation in rats during day 30-60, but these behaviors disappeared on day 90.Induced degeneration and simplification of the postsynaptic folds, widening of the synaptic clefts, increased number of the postsynaptic vesicles, and reduction in the number of the AChR in the postsynaptic membrane on days 360.
体外研究：
Ambenonium chloride inhibits Acetyicholinesterase (AChE) in a rapidly reversible method, and shows strong inhibition with inhibition constant Ki of 0.12 nM against hAChE.Ambenonium chloride shows inhibitory effect towards BChE with an IC50 value of 7 μM (hBChE).
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备